Cell-line research
The description discusses WJ-MSC-derived cell lines and reprogramming approaches.
An inventor record, in context.
Dr. Senem Şimşek is a named co-inventor on WO2023223303A1, a published international patent application related to cell lines and computational manufacturing.
WO2023223303A1
Novel cell lines and systems and methods for a machine learning manufacturing software platform that optimize unique functional ingredients and solutions for the biotech and foodtech industries
Published international patent applicationWhat the document describes
The disclosure includes Wharton's Jelly-derived mesenchymal stromal cell (WJ-MSC) reprogramming and an AI/ML manufacturing platform connecting cell-culture, imaging and omics information.
Read more
Computational manufacturing
The disclosed system links biological data and computational modules for biotech and foodtech workflows.
Publication, status and company rights
A1 is the international application publication. Grant status and Rnevox ownership, licensing or exclusivity require separate records.
Read more
Named parties
Inventors: Sofia Giampaoli and Senem Simsek. Published applicant: ALT ATLAS LTD. Google Patents also lists Alt Atlas Ltd as assignee.
Publication history
Priority: 20 May 2022. International filing: 22 May 2023. Publication: 23 November 2023. Application: PCT/IB2023/055253.
Recorded status
Google Patents labels this WO record "Ceased", checked 11 October 2026. This is a database label, not a legal opinion on national filings or the entire patent family.
Rnevox relationship
Inventorship is documented. Rnevox ownership, a licence and exclusive rights have not been confirmed in the materials supplied for this site.
Selected sources
Patent process
The PCT international and national phasesWIPO. National or regional offices decide whether to grant patents; publication of an international application is a separate step.